IL34722A - Carcinoembryonic antigen,its preparation and a method for detecting its presence in blood - Google Patents

Carcinoembryonic antigen,its preparation and a method for detecting its presence in blood

Info

Publication number
IL34722A
IL34722A IL34722A IL3472270A IL34722A IL 34722 A IL34722 A IL 34722A IL 34722 A IL34722 A IL 34722A IL 3472270 A IL3472270 A IL 3472270A IL 34722 A IL34722 A IL 34722A
Authority
IL
Israel
Prior art keywords
blood
detecting
preparation
carcinoembryonic antigen
carcinoembryonic
Prior art date
Application number
IL34722A
Other languages
English (en)
Other versions
IL34722A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL34722A0 publication Critical patent/IL34722A0/xx
Publication of IL34722A publication Critical patent/IL34722A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL34722A 1970-06-01 1970-06-15 Carcinoembryonic antigen,its preparation and a method for detecting its presence in blood IL34722A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3806970A 1970-06-01 1970-06-01

Publications (2)

Publication Number Publication Date
IL34722A0 IL34722A0 (en) 1970-08-19
IL34722A true IL34722A (en) 1974-03-14

Family

ID=21897920

Family Applications (2)

Application Number Title Priority Date Filing Date
IL34722A IL34722A (en) 1970-06-01 1970-06-15 Carcinoembryonic antigen,its preparation and a method for detecting its presence in blood
IL42508A IL42508A0 (en) 1970-06-01 1973-06-15 The preparation of antiserum specific for carcinoembryonic antigen

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL42508A IL42508A0 (en) 1970-06-01 1973-06-15 The preparation of antiserum specific for carcinoembryonic antigen

Country Status (14)

Country Link
US (1) US3663684A (da)
JP (4) JPS5122047B1 (da)
BE (1) BE767800A (da)
CA (1) CA964580A (da)
CH (2) CH615439A5 (da)
DE (2) DE2065867B2 (da)
DK (1) DK144591C (da)
FR (1) FR2095728A5 (da)
GB (4) GB1321997A (da)
IL (2) IL34722A (da)
IT (1) IT995014B (da)
NL (2) NL7107501A (da)
SE (1) SE400124B (da)
ZA (1) ZA704069B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4022876A (en) * 1973-06-21 1977-05-10 Stanford Research Institute Mass spectrometric immunoassay
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4132767A (en) * 1976-04-05 1979-01-02 Eisai Co., Ltd. Preparation of α-L antibody, purification of α-L antigen and reagent for detection of α-L antibody and α-L antigen
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4160817A (en) * 1976-09-29 1979-07-10 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4180556A (en) * 1977-03-09 1979-12-25 Abbott Laboratories Pretreatment method for carcinoembryonic antigen assay
JPS548714A (en) * 1977-06-16 1979-01-23 Saikin Kagaku Kenkiyuushiyo Kk Production of specific antiserum
US4234476A (en) * 1978-03-07 1980-11-18 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
US4241044A (en) * 1978-12-28 1980-12-23 Abbott Laboratories Method of diagnosing cancer by detecting elevated anti-T antibody activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4299815A (en) * 1980-02-08 1981-11-10 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4317877A (en) * 1980-06-05 1982-03-02 Sloan Kettering Institute Process for detecting the presence of malignant and pre-malignant cells in humans
US4559311A (en) * 1981-08-27 1985-12-17 Stenman Ulf Hakan Diagnostic method using oncofetal peptide as a tumor marker
FR2520235A1 (fr) * 1982-01-27 1983-07-29 Bel Fromageries Procede de separation d'immunoglobulines a partir de colostrum
US4863853A (en) * 1982-04-21 1989-09-05 Bartos Patent Development And Holding Company Limited Method of determining the diagnostic value of monitoring serum-CEA-levels in a carcinoma patient undergoing therapy
DE3230299A1 (de) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung
DK557483A (da) * 1982-12-06 1984-06-07 Hoffmann La Roche Fremgangsmaade til bestemmelse af cea
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
JPS63187697U (da) * 1987-05-26 1988-12-01
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
US5705351A (en) * 1994-10-25 1998-01-06 Sahasrabudhe; Madhao B. Diagnosis of cancer using tumor-mimetic cell surface antigen from chemically modified normal cells
US5635361A (en) * 1994-10-25 1997-06-03 Sahasrabudhe; Madhao B. Diagnosis of cancer using tumor-mimetic cell surface antigen from chemically modified normal cells
EP1803814A1 (en) 2005-12-27 2007-07-04 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Method of improving the antibody selection capacity in phage-display library
JP7060510B2 (ja) * 2016-09-06 2022-04-26 富士レビオ株式会社 腫瘍マーカーの測定方法及び測定試薬

Also Published As

Publication number Publication date
IL34722A0 (en) 1970-08-19
IT995014B (it) 1975-11-10
DK144591C (da) 1982-09-20
JPS5617619B1 (da) 1981-04-23
JPS5122047B1 (da) 1976-07-07
DE2029499C3 (de) 1983-12-22
FR2095728A5 (da) 1972-02-11
GB1322000A (en) 1973-07-04
NL7801570A (nl) 1978-06-30
DE2029499B2 (de) 1976-10-28
CH615439A5 (da) 1980-01-31
CA964580A (en) 1975-03-18
JPS5327334B1 (da) 1978-08-08
US3663684A (en) 1972-05-16
CH611629A5 (da) 1979-06-15
ZA704069B (en) 1972-01-26
DK144591B (da) 1982-04-05
JPS5516267B1 (da) 1980-04-30
GB1321997A (en) 1973-07-04
BE767800A (fr) 1971-11-29
DE2029499A1 (de) 1971-12-16
NL7107501A (da) 1971-12-03
GB1321998A (en) 1973-07-04
DE2065867B2 (de) 1980-06-04
GB1321999A (en) 1973-07-04
DE2065867A1 (de) 1976-09-16
IL42508A0 (en) 1973-08-29
SE400124B (sv) 1978-03-13

Similar Documents

Publication Publication Date Title
IL34722A (en) Carcinoembryonic antigen,its preparation and a method for detecting its presence in blood
JPS5597327A (en) Method and device for collecting vessel
ZA728798B (en) Direct radioimmunoassay for antigens and their antibodies
IL36950A0 (en) Carcinoembryonic antigen,its production and use
JPS5293897A (en) Method and device for separating isotope
ZA711763B (en) Clinical specimen collecting method and means
NZ179988A (en) A composition, and a method using it, for the detection ofhepatitis b antigen in human blood
IL38091A0 (en) Method for diffusion bonding
YU34449B (en) Device for making tunnels and underminings using shield-method
ZA723577B (en) Merchandise bagging device and method
CA963180A (en) Methods and system for detecting subsurface minerals
ZA704764B (en) A method and means for heat bonding
IL36518A0 (en) Method and device for detecting leaks
ZA712884B (en) Footwear,method and device for the manufacture thereof
IL35515A0 (en) A hydrophilic copolymer and a method for its preparation
IL39991A0 (en) Method and reagent for detecting australia antigen
ZA73532B (en) Prostaglandins and methods for preparing same
ZA732509B (en) Improvement in geochemical prospecting
CA960757A (en) Synchronous detecting device
IL36691A0 (en) Shoe,method and device for its manufacture
CA951167A (en) Development restrainer in diffusion transfer
CA942555A (en) Development method and materials
ZA711418B (en) Method and preparations for obtaining diureses in animals including man
CA966778A (en) Antigens and antibodies
ATA402674A (de) Verfahren zur herstellung von flaschenkapseln